Paloma Partners’s Idexx Laboratories IDXX Stock Holding History

Paloma Partners’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3,500	Closed	-$1.77M	–	649
2024 Q3	$1.77M	Sell	3,500 -4,500	-56%	-$2.19M	0.05%	307
2024 Q2	$3.9M	Buy	+8,000	New	+$4.02M	0.11%	182
2023 Q2	–	Sell	-1,900	Closed	-$950K	–	846
2023 Q1	$950K	Buy	+1,900	New	+$909K	0.03%	380
2022 Q4	–	Sell	-3,400	Closed	-$1.11M	–	1032
2022 Q3	$1.11M	Buy	+3,400	New	+$1.25M	0.05%	304
2017 Q4	–	Sell	-10,000	Closed	-$1.55M	–	2073
2017 Q3	$1.55M	Buy	+10,000	New	+$1.58M	0.02%	900

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Paloma Partners's IDXX Position: Q2 2025 in Review

Paloma Partners sold out of Idexx Laboratories (IDXX) in Q2 2025, closing a stake of 659 shares — an estimated $277K sold.

Paloma Partners first reported a position in IDXX in Q2 2013 and held it in 25 quarters. The position peaked at $5.1M in Q3 2015. 1,235 funds tracked by Wall St. Rank hold IDXX as of Q2 2025.

Paloma Partners reported no remaining Idexx Laboratories position as of Q2 2025 after selling out during the quarter.
Paloma Partners sold 659 Idexx Laboratories shares in Q2 2025, an estimated $277K.
Paloma Partners first reported a position in Idexx Laboratories in Q2 2013 and held it in 25 quarters.
Paloma Partners's Idexx Laboratories position peaked at $5.1M in Q3 2015.
1,235 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2025.

Based on Paloma Partners's 13F filing for Q2 2025, filed 14 Aug 2025.